MARATTO

article · Scientific Reports

Predictors associated with time to default for HIV/AIDS patients under HAART at Debre Tabor Referral Hospital: a Cox regression model

20251 citationOpen accessDebre Tabor University

Abstract

The human immunodeficiency virus systematically undermines the immune system, which serves as our body's inherent safeguard against diseases. Currently, it is the most serious threat to public health. Ethiopia is among the countries with the highest prevalence of HIV/AIDS. Defaulting is still a public health issue that must be resolved in order to maximize HAART's benefits. Thus, this study was aimed to assess the proportion of HAART defaulters and to identify associated factors that lead to defaulting from HAART. Data from 230 study participants was analyzed using a Cox PH regression model. The study found that patients who did not adhere to at least 95% of their regimen had a higher risk of defaulting from HAART relative to those who did adhere to at least 95% [HR = 2.924, 95% CI: 2.113, 4.047]. To advance the longevity of HIV/AIDS-infected patients within HAART medication, an intervention should be taken from the concerned body for those patients who had been at high risk of defaulting during initial and some stages of treatment. Interventions might include: following home-based treatment options; mobile health technology; granting access road facilities; accessing fast diagnostic testing procedure; giving medical advice to disclose; giving receive financial support.

Research topics

  • HIV/AIDS Research and Interventions
  • HIV, Drug Use, Sexual Risk
  • Hepatitis C virus research

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1038/s41598-024-83335-1

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.